SUBSCRIBE
SUBSCRIBE
News   Deals

India’s BioCon Limited to Buy U.S. Firm for $400M

April 14, 2008 | 
1 min read
MUMBAI, April 14 (Reuters) - India's top biotechnology firm, Biocon Ltd, is in talks to acquire a U.S. firm in a deal valued at $400 million to boost its overseas pharmaceutical distribution network, the Mint newspaper reported on Monday.
Mergers & acquisitions Asia
BioCon Limited
MORE ON THIS TOPIC
Illustration of two arrows merging into one
Mergers & acquisitions
BioMarin Expands Enzyme Expertise With $270M Inozyme Buy
May 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Vector of a woman holds her hand near ear and listens carefully isolated on blue background
RNA editing
Lilly Makes $1.3B RNA Editing Bet With Rznomics to Build Out Hearing Loss Pipeline
May 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Halftone hands shake coins out of paper money. Modern collage. Concept of inflation, bankruptcy, poverty. Financial difficulties
Deals
Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders
May 15, 2025
 · 
1 min read
Close the deal by shaking hands. Art collage. Orange circle in the center.
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
 · 
2 min read
 · 
Dan Samorodnitsky